Back to top

blockchain: Archive

Zacks Equity Research

Is JPMorgan Intrepid Value Fund A (JIVAX) a Strong Mutual Fund Pick Right Now?

Mutual Fund Report for JIVAX

Zacks Equity Research

Is iShares S&P 500 Index K (WFSPX) a Strong Mutual Fund Pick Right Now?

Mutual Fund Report for WFSPX

WFSPXPositive Net Change

Zacks Equity Research

Roivant Sciences Ltd. (ROIV) Soars 5.8: Is Further Upside Left in the Stock?

Roivant Sciences Ltd. (ROIV) was a big mover last session on higher-than-average trading volume. The latest trend in earnings estimate revisions might not help the stock continue moving higher in the near term.

ROIVNegative Net Change

Zacks Equity Research

Strength Seen in Arista Networks (ANET): Can Its 9.3% Jump Turn into More Strength?

Arista Networks (ANET) saw its shares surge in the last session with trading volume being higher than average. The latest trend in earnings estimate revisions may not translate into further price increase in the near term.

ANETPositive Net Change ATUSNegative Net Change

Zacks Equity Research

Calumet Specialty Products Partners, L.P. (CLMT) Stock Jumps 5.5%: Will It Continue to Soar?

Calumet Specialty Products Partners, L.P. (CLMT) saw its shares surge in the last session with trading volume being higher than average. The latest trend in earnings estimate revisions could translate into further price increase in the near term.

CLMTPositive Net Change TRGPPositive Net Change

Zacks Equity Research

360 DigiTech, Inc. Sponsored ADR (QFIN) Soars 7.1%: Is Further Upside Left in the Stock?

360 DigiTech, Inc. Sponsored ADR (QFIN) saw its shares surge in the last session with trading volume being higher than average. The latest trend in earnings estimate revisions may not translate into further price increase in the near term.

QFINNegative Net Change COHRPositive Net Change

Zacks Equity Research

Strength Seen in Helmerich & Payne (HP): Can Its 11.2% Jump Turn into More Strength?

Helmerich & Payne (HP) saw its shares surge in the last session with trading volume being higher than average. The latest trend in earnings estimate revisions could translate into further price increase in the near term.

HPPositive Net Change RIGNegative Net Change

Zacks Equity Research

e.l.f. Beauty (ELF) is an Incredible Growth Stock: 3 Reasons Why

e.l.f. Beauty (ELF) is well positioned to outperform the market, as it exhibits above-average growth in financials.

ELFPositive Net Change

Zacks Equity Research

Here is Why Growth Investors Should Buy OP Bancorp (OPBK) Now

OP Bancorp (OPBK) is well positioned to outperform the market, as it exhibits above-average growth in financials.

OPBKNegative Net Change

Zacks Equity Research

Is GoDaddy (GDDY) a Solid Growth Stock? 3 Reasons to Think "Yes"

GoDaddy (GDDY) is well positioned to outperform the market, as it exhibits above-average growth in financials.

GDDYNegative Net Change

Zacks Equity Research

Looking for a Growth Stock? 3 Reasons Why Boyd (BYD) is a Solid Choice

Boyd (BYD) is well positioned to outperform the market, as it exhibits above-average growth in financials.

BYDNegative Net Change

Zacks Equity Research

Is CF (CF) a Solid Growth Stock? 3 Reasons to Think "Yes"

CF (CF) could produce exceptional returns because of its solid growth attributes.

CFPositive Net Change

Zacks Equity Research

What Makes Pebblebrook Hotel (PEB) a New Buy Stock

Pebblebrook Hotel (PEB) might move higher on growing optimism about its earnings prospects, which is reflected by its upgrade to a Zacks Rank #2 (Buy).

PEBNo Net Change

Zacks Equity Research

All You Need to Know About Ocuphire Pharma, Inc. (OCUP) Rating Upgrade to Buy

Ocuphire Pharma, Inc. (OCUP) might move higher on growing optimism about its earnings prospects, which is reflected by its upgrade to a Zacks Rank #2 (Buy).

Zacks Equity Research

Genius Sports Limited (GENI) Moves to Buy: Rationale Behind the Upgrade

Genius Sports Limited (GENI) has been upgraded to a Zacks Rank #2 (Buy), reflecting growing optimism about the company's earnings prospects. This might drive the stock higher in the near term.

GENIPositive Net Change

Zacks Equity Research

AxoGen (AXGN) Upgraded to Buy: Here's What You Should Know

AxoGen (AXGN) might move higher on growing optimism about its earnings prospects, which is reflected by its upgrade to a Zacks Rank #2 (Buy).

AXGNPositive Net Change

Zacks Equity Research

ADP (ADP) Upgraded to Buy: Here's What You Should Know

ADP (ADP) might move higher on growing optimism about its earnings prospects, which is reflected by its upgrade to a Zacks Rank #2 (Buy).

ADPPositive Net Change

Zacks Equity Research

Why Is BlackBerry (BB) Down 9.2% Since Last Earnings Report?

BlackBerry (BB) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.

BBNegative Net Change ADBENegative Net Change

Zacks Equity Research

United Natural (UNFI) Up 14.1% Since Last Earnings Report: Can It Continue?

United Natural (UNFI) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.

UNFIPositive Net Change

Zacks Equity Research

Neogen (NEOG) Down 13.6% Since Last Earnings Report: Can It Rebound?

Neogen (NEOG) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.

NEOGPositive Net Change

Zacks Equity Research

Jabil (JBL) Up 6.7% Since Last Earnings Report: Can It Continue?

Jabil (JBL) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.

JBLPositive Net Change

Zacks Equity Research

Why Is Synnex (SNX) Up 5.2% Since Last Earnings Report?

Synnex (SNX) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.

SNXPositive Net Change